Parschauer Karah Herdman

Tenaya Therapeutics, Inc. ยท Director

Parschauer Karah Herdman is listed in public filings as director. This Parschauer Karah Herdman insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Tenaya Therapeutics, Inc. (TNYA), Ultragenyx Pharmaceutical Inc (RARE), and Evolus, Inc. (EOLS). Investors use Parschauer Karah Herdman's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Tenaya Therapeutics, Inc.TNYA$96k120k sharesGrant / ExerciseMay 28, 2026$95.9K120k shares$0.7989--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Ultragenyx Pharmaceutical IncRARE$1.2M50k sharesGrant / ExerciseApr 16, 2026$1.2M50k shares$24.52--
Ultragenyx Pharmaceutical IncRARE--95.7k sharesGrant / ExerciseApr 16, 2026Disclosure amount unavailable28.9k shares----
Ultragenyx Pharmaceutical IncRARE$1.5M66.8k sharesSellMar 10, 2026$79.5K3.5k shares$22.67--
Ultragenyx Pharmaceutical IncRARE$1.5M70.3k sharesSellMar 6, 2026$128.8K6k shares$21.40--
Ultragenyx Pharmaceutical IncRARE$1.7M76.3k sharesSellMar 2, 2026$185.5K8.1k shares$22.80--
Ultragenyx Pharmaceutical IncRARE--84.4k sharesGrant / ExerciseMar 1, 2026Disclosure amount unavailable11.1k shares----
Evolus, Inc.EOLS--77.7k sharesGrant / ExerciseFeb 17, 2026Disclosure amount unavailable45.6k shares----
Ultragenyx Pharmaceutical IncRARE$2.3M73.3k sharesSellSep 12, 2025$76.4K2.5k shares$31.17--
Tenaya Therapeutics, Inc.TNYA$48k107.4k sharesGrant / ExerciseMay 29, 2025$47.7K107.4k shares$0.4444--
Evolus, Inc.EOLS$418k32.2k sharesSellMar 12, 2025$167.5K12.9k shares$12.99--
Evolus, Inc.EOLS--45.1k sharesGrant / ExerciseMar 7, 2025Disclosure amount unavailable7.4k shares----
Evolus, Inc.EOLS$151k11.1k sharesGrant / ExerciseMar 7, 2025$151.4K11.1k shares$13.58--
Ultragenyx Pharmaceutical IncRARE$3.2M75.3k sharesSellMar 3, 2025$540.8K12.8k shares$42.10--
Ultragenyx Pharmaceutical IncRARE$1.1M26.1k sharesGrant / ExerciseMar 1, 2025$1.1M26.1k shares$42.92--
Ultragenyx Pharmaceutical IncRARE--69.7k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable14.5k shares----
Ultragenyx Pharmaceutical IncRARE--88.1k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable18.4k shares----
Ultragenyx Pharmaceutical IncRARE$2.4M55.8k sharesSellFeb 27, 2025$95.7K2.2k shares$42.93--
Ultragenyx Pharmaceutical IncRARE$2.4M55k sharesSellFeb 27, 2025$32.5K760 shares$42.75--
Tenaya Therapeutics, Inc.TNYA$69k34k sharesGrant / ExerciseOct 18, 2024$69.4K34k shares$2.04--
Ultragenyx Pharmaceutical IncRARE$2.6M58k sharesSellJun 12, 2024$441.3K9.8k shares$45.00--